Business Wire

“Our Future is Light” Campaign Kicks off 2022 International Day of Light

Share

An action-packed video styled as a blockbuster-movie trailer provides the linchpin for this year’s International Day of Light (IDL) campaign, “Our future is light. Play your part.” Released today, Day of Light features diverse characters successfully solving global-level problems using photonics-enabled technologies.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220516005150/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Sponsored by SPIE, Optica, and IEEE Photonics Society, this year’s International Day of Light celebration showcases exciting, critical career opportunities in optics and photonics. (Graphic: Business Wire)

Three professional societies – SPIE, the international society for optics and photonics, IEEE Photonics Society, and Optica, Advancing Optics & Photonics Worldwide – partnered to create the video and the accompanying 2022 IDL campaign. “Our future is light. Play your part” promotes the importance of light-based technologies and interesting careers in optics and photonics, while raising awareness of the annual IDL celebration on 16 May. From technologies that improve vision and power smartphones to those that provide tools to study Earth and Space, from healthcare to communications at the speed of light, photonics is the key enabling technology of a brighter future.

The video, its look and feel inspired by the 2010 science-fiction thriller Inception, features Dawn, an optical-engineer action hero, who is busy saving the world with light-based technologies such as prisms, solar panels, spectral imaging, lasers, and lidar. The video also issues a lively invitation to real-life future scientists, technicians, engineers, and industry leaders: consider a career in photonics.

In conjunction with the video’s release, the related website includes an overview of the technologies mentioned in the film; depictions of professionals working in the field of optics and photonics, from optical engineers and laser technicians to academic researchers; and a selection of downloadable resources for education and careers.

“Many of the devices we use every day are comprised of light-based technologies made possible by the optics and photonics community,” said Optica CEO Elizabeth Rogan. “On the International Day of Light, we celebrate these contributions from our community and hope this celebration inspires others – particularly students – to study and work in light science and technology.”

“The International Day of Light is the perfect time to highlight the many varied and exciting career opportunities in optics and photonics,” noted SPIE CEO Kent Rochford. “Light-based technologies are providing much-needed solutions to some of our biggest global challenges and will continue to do so. This is a terrific time to be considering a career in the industry and we hope this year’s IDL campaign will reach and inspire future scientists, engineers, and technicians.”

"Each International Day of Light, we celebrate the long and rich history of optics and photonics that has brought so much to our everyday lives," said IEEE Photonics Society Executive Director Doug Razzano. "By continuing to advance light science and make known to the world the importance of the technologies derived from it, we will help to grow and support this vibrant technical community."

About the International Day of Light

The International Day of Light (IDL), celebrated annually on 16 May, is a global initiative highlighting the central role that light and light-based technologies play across science, culture, education, and sustainable development, in areas as diverse as medicine, communications, and energy. The 16 May date honors the anniversary of the first successful demonstration of a laser by physicist and engineer Theodore Maiman in 1960; the broad theme of light allows many different sectors of society worldwide to participate in activities that demonstrate how science, technology, and art, can help achieve the goals of UNESCO – education, equality, and peace. lightday.org.

About IEEE Photonics Society

The IEEE Photonics Society is the professional home for a global network of scientists, engineers and allied professionals who represent the laser, optoelectronics, and photonics community. As a Technical Society of the IEEE, the world’s largest technical professional organization dedicated to advancing technology for the benefit of humanity, the IEEE Photonics Society inspires community through highly cited publications, conferences, technology standards, and professional and educational activities. www.photonicssociety.org.

About Optica

Optica (formerly OSA), Advancing Optics and Photonics Worldwide, is the society dedicated to promoting the generation, application, archiving and dissemination of knowledge in the field. Founded in 1916, it is the leading organization for scientists, engineers, business professionals, students and others interested in the science of light. Optica’s renowned publications, meetings, online resources and in-person activities fuel discoveries, shape real-life applications and accelerate scientific, technical and educational achievement. Learn more at optica.org.

About SPIE

SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. The Society, founded in 1955, connects and engages with our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. Over the past five years, SPIE has contributed more than $22 million to the international optics community through our advocacy and support, including scholarships, educational resources, travel grants, endowed gifts, and public-policy development. www.spie.org.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Daneet Steffens
Public Relations Manager
daneets@spie.org
+1 360 685 5478
@SPIEtweets

Ashley Collier
Corporate Communications Manager
ACollier@optica.org
+1 202 416 1419
@OpticaWorldwide

Kristen Mahan
Marketing Manager
k.mahan@ieee.org
+1 732 562 6694
@IEEEPhotonics

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye